These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 33451103)

  • 1. FOLFOX Therapy Induces Feedback Upregulation of CD44v6 through YB-1 to Maintain Stemness in Colon Initiating Cells.
    Ghatak S; Hascall VC; Markwald RR; Misra S
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33451103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schlafen-3 decreases cancer stem cell marker expression and autocrine/juxtacrine signaling in FOLFOX-resistant colon cancer cells.
    Oh PS; Patel VB; Sanders MA; Kanwar SS; Yu Y; Nautiyal J; Patel BB; Majumdar AP
    Am J Physiol Gastrointest Liver Physiol; 2011 Aug; 301(2):G347-55. PubMed ID: 21596996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy induces feedback up-regulation of CD44v6 in colorectal cancer initiating cells through
    Ghatak S; Hascall VC; Karamanos N; Markwald RR; Misra S
    Front Oncol; 2022; 12():906260. PubMed ID: 36330477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer-initiating cells derived from human rectal adenocarcinoma tissues carry mesenchymal phenotypes and resist drug therapies.
    Fan CW; Chen T; Shang YN; Gu YZ; Zhang SL; Lu R; OuYang SR; Zhou X; Li Y; Meng WT; Hu JK; Lu Y; Sun XF; Bu H; Zhou ZG; Mo XM
    Cell Death Dis; 2013 Oct; 4(10):e828. PubMed ID: 24091671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay Between Chemotherapy-Activated Cancer Associated Fibroblasts and Cancer Initiating Cells Expressing CD44v6 Promotes Colon Cancer Resistance.
    Ghatak S; Hascall VC; Karamanos N; Markwald RR; Misra S
    Front Oncol; 2022; 12():906415. PubMed ID: 35982950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirement of the transcription factor YB-1 for maintaining the stemness of cancer stem cells and reverting differentiated cancer cells into cancer stem cells.
    Yang F; Cui P; Lu Y; Zhang X
    Stem Cell Res Ther; 2019 Aug; 10(1):233. PubMed ID: 31375149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells.
    Cheng W; Liu T; Wan X; Gao Y; Wang H
    FEBS J; 2012 Jun; 279(11):2047-59. PubMed ID: 22498306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel role of O-glycosyltransferases GALNT3 and B3GNT3 in the self-renewal of pancreatic cancer stem cells.
    Barkeer S; Chugh S; Karmakar S; Kaushik G; Rauth S; Rachagani S; Batra SK; Ponnusamy MP
    BMC Cancer; 2018 Nov; 18(1):1157. PubMed ID: 30466404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Musashi2 contributes to the maintenance of CD44v6+ liver cancer stem cells via notch1 signaling pathway.
    Wang X; Wang R; Bai S; Xiong S; Li Y; Liu M; Zhao Z; Wang Y; Zhao Y; Chen W; Billiar TR; Cheng B
    J Exp Clin Cancer Res; 2019 Dec; 38(1):505. PubMed ID: 31888685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the thyroid hormone T3 and its nuclear receptor TRĪ±1 on colon cancer stem cell phenotypes and response to chemotherapies.
    Giolito MV; Bodoirat S; La Rosa T; Reslinger M; Guardia GDA; Mourtada J; Claret L; Joung A; Galante PAF; Penalva LOF; Plateroti M
    Cell Death Dis; 2024 May; 15(5):306. PubMed ID: 38693105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deregulation of the CD44-NANOG-MDR1 associated chemoresistance pathways of breast cancer stem cells potentiates the anti-cancer effect of Kaempferol in synergism with Verapamil.
    Nandi SK; Roychowdhury T; Chattopadhyay S; Basu S; Chatterjee K; Choudhury P; Banerjee N; Saha P; Mukhopadhyay S; Mukhopadhyay A; Bhattacharya R
    Toxicol Appl Pharmacol; 2022 Feb; 437():115887. PubMed ID: 35063459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silibinin, A Natural Blend In Polytherapy Formulation For Targeting Cd44v6 Expressing Colon Cancer Stem Cells.
    Patel S; Waghela B; Shah K; Vaidya F; Mirza S; Patel S; Pathak C; Rawal R
    Sci Rep; 2018 Nov; 8(1):16985. PubMed ID: 30451890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a subpopulation of long-term tumor-initiating cells in colon cancer.
    Peng L; Xiong Y; Wang R; Xiang L; Zhou H; Gu H
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32729895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivery of CD44 shRNA/nanoparticles within cancer cells: perturbation of hyaluronan/CD44v6 interactions and reduction in adenoma growth in Apc Min/+ MICE.
    Misra S; Hascall VC; De Giovanni C; Markwald RR; Ghatak S
    J Biol Chem; 2009 May; 284(18):12432-46. PubMed ID: 19246453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NONO and RALY proteins are required for YB-1 oxaliplatin induced resistance in colon adenocarcinoma cell lines.
    Tsofack SP; Garand C; Sereduk C; Chow D; Aziz M; Guay D; Yin HH; Lebel M
    Mol Cancer; 2011 Nov; 10():145. PubMed ID: 22118625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Y-box binding protein-1 induces the expression of CD44 and CD49f leading to enhanced self-renewal, mammosphere growth, and drug resistance.
    To K; Fotovati A; Reipas KM; Law JH; Hu K; Wang J; Astanehe A; Davies AH; Lee L; Stratford AL; Raouf A; Johnson P; Berquin IM; Royer HD; Eaves CJ; Dunn SE
    Cancer Res; 2010 Apr; 70(7):2840-51. PubMed ID: 20332234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knock out CD44 in reprogrammed liver cancer cell C3A increases CSCs stemness and promotes differentiation.
    Han S; Guo J; Liu Y; Zhang Z; He Q; Li P; Zhang M; Sun H; Li R; Li Y; Zeng W; Liu J; Lian L; Gao Y; Shen L
    Oncotarget; 2015 Dec; 6(42):44452-65. PubMed ID: 26540347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of CD44v6 contributes to acquired chemoresistance via the modulation of autophagy in colon cancer SW480 cells.
    Lv L; Liu HG; Dong SY; Yang F; Wang QX; Guo GL; Pan YF; Zhang XH
    Tumour Biol; 2016 Jul; 37(7):8811-24. PubMed ID: 26747179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etoposide enhances antitumor efficacy of MDR1-driven oncolytic adenovirus through autoupregulation of the MDR1 promoter activity.
    Su BH; Shieh GS; Tseng YL; Shiau AL; Wu CL
    Oncotarget; 2015 Nov; 6(35):38308-26. PubMed ID: 26515462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction between PDCD4 and YB1 is critical for cervical cancer stemness and cisplatin resistance.
    Liu D; Ke J; Liu Y; Rao H; Tang Z; Liu Y; Zhang Z; You L; Luo X; Sun Z; He Z; Li F; Qiu Z; Hu J; Mbadhi MN; Tang J; Wu F; Li S
    Mol Carcinog; 2021 Dec; 60(12):813-825. PubMed ID: 34499772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.